Table 5.
Group | Administration/Treatment | Concentration mg/dl | ||||
---|---|---|---|---|---|---|
Total cholesterol | Triglycerides | HDL- cholesterol | VLDL- cholesterol | LDL- cholesterol m | ||
I | Normal | 84.5 ± 3.33a | 71.5 ± 2.81a | 31.62 ± 2.06a | 14.3 ± 0.38a | 38.58 ± 1.5a |
II | Diabetic | 199.8 ± 3.5b | 179.2 ± 2.30b | 17.1 ± 0.92b | 35.84 ± 0.66b | 146.86 ± 2.32b |
III | Xiaoke pill | 102.3 ± 2.38c | 79.2 ± 1.14c | 24.3 ± 0.11c | 20.46 ± 0.93c | 57.54 ± 1.45c |
IV | Crude polysaccharide | 116.1 ± 2.38d | 77.6 ± 1.45 d | 26.4 ± 0.65 d | 23.22 ± 0.86 d | 66.48 ± 2.11 d |
V | Rhamnose enriched polysaccharide | 93.2 ± 2.38e | 71.6 ± 1.45e | 32.3 ± 1.88e | 18.64 ± 0.69e | 42.26 ± 1.6e |
a,b,c,d&eComparisons were made between Groups I, II, III, IV and V.